David Bayne, MD, MPH, was recently awarded a K23 titled “Use of the electronic health record to target a patient navigation intervention preventing loss to follow up in the treatment of urinary stone disease.”
Dr. Bayne is a K12 alumnus from the CAIRIBU UCSF-Kaiser Permanente KUroEpi Program (PI, Alison Huang, MD, MPhil, MAS). He is now an Assistant Professor of Urology at the University of California San Francisco.
This award will provide him with training and research experience to: (1) leverage electronic health record (EHR) data to streamline the identification of patients at risk for being lost to follow up (LTFU) after diagnosis of urinary stone disease (USD) in the emergency department (ED); (2) elucidate stakeholder perspectives on root causes of, and potential solutions for, LTFU; and (3) evaluate acceptability and feasibility of early risk identification paired with patient navigator support as a pilot intervention to reduce LTFU for USD. Dr. Bayne has assembled an ideal team composed of co-mentors, Dr. Marshall Stoller and Dr. Charles Scales, experts in clinical trial design and implementation for USD.
Dr. Bayne will build on findings from his prior work showing a consistent, independent association between delays in urologic care for USD and multiple EHR-derived predictors that correspond to low socioeconomic status (e.g. insurance, demographic information, community level data).
This award will facilitate his transition to an independent clinician-researcher focused on studying and reducing disparities in treatment outcomes for USD. Dr. Bayne represents the CAIRIBU community’s mission to increase research of non-malignant urologic conditions.
Congratulations, Dr. Bayne!